Stage-dependent effects of 20-hydroxyecdysone on DNA synthesis of corpus allatum cells in the silkworm,Bombyx mori

✍ Scribed by Gu, Shi-Hong ;Chow, Yien-Shing

• Publisher: John Wiley and Sons
• Year: 2003
• Tongue: English
• Weight: 151 KB
• Volume: 297A
• Category: Article
• ISSN: 0022-104X
• DOI: 10.1002/jez.a.10231

✦ Synopsis

Abstract

DNA synthesis in cells of the corpus allata (CA) of the silkworm, Bombyx mori, was studied immunocytochemically after in vivo labeling with 5‐bromo‐2'‐deoxyuridine (BrdU); developmental changes during the 3^rd^, 4^th^, and last larval instars and effects of 20‐hydroxyecdysone treatment were examined. During both the 3^rd^ and 4^th^ larval instars, the number of DNA‐synthesizing cells fluctuated, and relatively low levels were observed during the middle stages. On day 0 of the last larval instar, the number of DNA‐synthesizing cells per gland was 9.2, which then increased on day 1 and remained at levels ranging from 12.9 and 16.9 cells per gland. A major peak level (28 BrdU‐labeled cells per gland) occurred on day 8, two days after larvae entered the wandering stage. When last instar larvae were fed 20‐hydroxyecdysone‐supplemented mulberry leaves starting on day 0 or 1, the number of DNA‐synthesizing cells dramatically decreased to very low levels and these low levels were maintained throughout the remainder of the instar. However, no effect was observed when last instar larvae were fed 20‐hydroxyecdysone‐supplemented mulberry leaves starting on day 3, indicating the stage‐specific action of 20‐hydroxyecdysone. The mechanism by which 20‐hydroxyecdysone treatment inhibits DNA synthesis of CA cells was further examined by using continuous in vitro BrdU labeling for a 2‐day incubation. It was found that the decrease in responsiveness of DNA synthesis of CA cells of 20‐hydroxyecdysone‐treated larvae to stimu‐lation by growth factors from hemolymph may have been, at least in part, responsible for the indirect inhibitory effects of 20‐hydroxyecdysone. J. Exp. Zool. 297A:138–146, 2003. © 2003 Wiley‐Liss, Inc.